CoxKAN: Kolmogorov-Arnold networks for interpretable, High-Performance survival analysis.
Published version
Peer-reviewed
Repository URI
Repository DOI
Loading...
Type
Change log
Abstract
Motivation
Survival analysis is a branch of statistics that is crucial in medicine for modeling the time to critical events such as death or relapse, in order to improve treatment strategies and patient outcomes. Selecting survival models often involves a trade-off between performance and interpretability; deep learning models offer high performance but lack the transparency of more traditional approaches. This poses a significant issue in medicine, where practitioners are reluctant to use black-box models for critical patient decisions.Results
We introduce CoxKAN, a Cox proportional hazards Kolmogorov-Arnold Network for interpretable, high-performance survival analysis. Kolmogorov-Arnold Networks (KANs) were recently proposed as an interpretable and accurate alternative to multi-layer perceptrons (MLPs). We evaluated CoxKAN on four synthetic and nine real datasets, including five cohorts with clinical data and four with genomics biomarkers. In synthetic experiments, CoxKAN accurately recovered interpretable hazard function formulae and excelled in automatic feature selection. Evaluations on real datasets showed that CoxKAN consistently outperformed the traditional Cox proportional hazards model (by up to 4% in C-index) and matched or surpassed the performance of deep learning-based models. Importantly, CoxKAN revealed complex interactions between predictor variables and uncovered symbolic formulae, which are key capabilities that other survival analysis methods lack, to provide clear insights into the impact of key biomarkers on patient risk.Availability and implementation
CoxKAN is available at GitHub and Zenodo.Supplementary information
Supplementary data are available at Bioinformatics online.Description
Journal Title
Bioinformatics (Oxford, England)
Conference Name
Journal ISSN
1367-4803
1367-4811
1367-4811
Volume Title
41
Publisher
Oxford University Press (OUP)
Publisher DOI
Rights and licensing
Except where otherwised noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/
Sponsorship
Mark Foundation for Cancer Research (RG95043)

